As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.
Fully-credentialled e-doctors still don’t exist, at least not in their entirety but major elements of the concept have already been deployed in the field, and progress toward a more comprehensive e-doc is well underway.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases